VPHIF (Valeo Pharma) Asset Impairment Charge : $2.17 Mil (TTM As of Jul. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Asset Impairment Charge?

Valeo Pharma's Asset Impairment Charge for the three months ended in Jul. 2024 was $0.42 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2024 was $2.17 Mil.

Valeo Pharma Asset Impairment Charge Historical Data

The historical data trend for Valeo Pharma's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Asset Impairment Charge Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Asset Impairment Charge

Get a 7-Day Free Trial

0.19

0.35

2.00

1.10

Valeo Pharma Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Asset Impairment Charge	Get a 7-Day Free Trial															0.22	0.81	0.83	0.11	0.42

Valeo Pharma Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.17 Mil.

Valeo Pharma Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.